Aurora Cannabis (TSE:ACB) Raised to “Hold” at BMO Capital Markets

Aurora Cannabis (TSE:ACB) was upgraded by BMO Capital Markets to a “hold” rating in a report released on Wednesday,Zacks.com reports.

Several other analysts have also recently weighed in on the company. TD dropped their price target on Aurora Cannabis from C$10.00 to C$8.00 and set a “buy” rating for the company in a report on Friday, June 12th. Canaccord Genuity Group decreased their price objective on Aurora Cannabis from C$6.50 to C$5.00 and set a “buy” rating on the stock in a report on Tuesday, June 30th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of C$7.17.

Aurora Cannabis Stock Down 0.5%

Aurora Cannabis stock opened at C$4.15 on Wednesday. The stock has a market cap of C$257.06 million, a P/E ratio of -1.94 and a beta of 0.25. The company has a quick ratio of 2.48, a current ratio of 5.36 and a debt-to-equity ratio of 4.30. Aurora Cannabis has a twelve month low of C$3.59 and a twelve month high of C$9.33. The company’s 50-day moving average price is C$4.08 and its two-hundred day moving average price is C$4.63.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Wednesday, August 5th. The company reported C($0.07) earnings per share (EPS) for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%.The company had revenue of C$67.55 million for the quarter. As a group, analysts expect that Aurora Cannabis will post -0.22 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.